president Donald Trump’s The Department of Health and Human Services (HHS) has concluded an award totaling more than $750 million, which was offered to drug manufacturer Moderna to promote the production of mRNA-based avian influenza vaccines.
During the final week of President Joe Biden’s inauguration, his administration awarded Moderna $590 million to speed up production of mRNA-based vaccines. The $590 million award followed the separate $176 million awards that Biden gave Moderna for MRNA last year. Vaccine Technology.
Messenger RNA vaccines are a new type of vaccine technology that companies such as Moderna and Pfizer have used to develop Covid-19 vaccines. Vaccine technology has been at the heart of many criticism amid the coronavirus pandemic as it could be linked to side effects in some people who took them, such as myocarditis.
On Wednesday, August 25th, 2021, the man receives his first dose of the Pfizer vaccine at the vaccination clinic at Long Speak Student Center at Front Range Community College in Fort Collins. (Jon Austria/The Coloradoan/USA Today Network)
Trump administration officials have previously suggested that the funds could end, citing a lack of surveillance during the Biden administration related to vaccine production.
“After a rigorous review, we concluded that Moderna’s ongoing investment in H5N1 mRNA vaccines cannot be scientifically or ethically justified,” said Andrew Nixon, director of HHS Communications. “This isn’t just about effectiveness, it’s about safety, integrity and trust. The reality is that mRNA technology remains under-tested and does not spend taxpayer dollars on repeating the mistakes of the public administration.
Protesters opposed the Covid-19 vaccine mandate and vaccine passport by a government rally at New York City City Hall on August 25, 2021. (Angelawice/AFP)
Trump FDA Overhaul Covid-19 Vaccine Approval Focused on Older Populations, High-Risk Individuals
The announcement reflects a greater change in federal vaccine priorities after HHS Secretary Robert F. Kennedy Jr. The Covid-19 vaccine was announced earlier this week. It will be deleted From the list of recommended vaccines for federal government children and pregnant women.
meanwhile, Report from Senate Republicans Released earlier this month suggests that the Biden administration withheld critical safety data and downplayed known risks linked to the mRNA COVID-19 vaccine. In particular, the Senate report focuses on the recognition and response of HHS, a type of cardiac inflammation, a case of myocarditis after Covid-19 vaccination.
HHS Director Robert F. Kennedy Jr. announced earlier this week that the federal government will remove the mRNA-based Covid-19 vaccine from its list of federal recommended vaccines for children and pregnant women. (Getty Images/Fox News)
“Instead of providing immediate and transparent information to public and healthcare providers about the risk of myocarditis after mRNA covid-19 vaccination; Biden administration Until late June 2021, we were waiting to announce a change in labeling for Moderni and Pfizer Covid-19 vaccines based on the “recommended increased risk” of myocarditis and pericarditis. Concerns, putting the health of young Americans at risk. ”
Click here to get the Fox News app
In response to the Trump administration’s filing of funds, Moderna came out Not only is it advertising the move, but also the “safety profile” observed during work with the new mRNA avian influenza vaccine.
“While the end of funding from HHS adds uncertainty, we are pleased with the robust immune response and safety profile observed in this preliminary analysis of the first/2 phase study of the H5 avian influenza vaccine. “These clinical data for pandemic influenza highlight the important role that MRNA technology has played in combating emerging health threats.”
Brooke Singman of Fox News Digital contributed to this report.
